» Articles » PMID: 17883327

Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation

Overview
Publisher Annual Reviews
Specialties Pharmacology
Toxicology
Date 2007 Sep 22
PMID 17883327
Citations 234
Authors
Affiliations
Soon will be listed here.
Abstract

The chemokine system coordinates leukocyte migration in immunity and inflammation and is implicated in the pathogenesis of many human diseases. Although several successful strategies have been identified to develop drugs targeting chemokines and their receptors, this has not yet resulted in many new therapeutics. This is likely due to a complexity of the chemokine system, which was not initially appreciated, that is characterized by redundancy, pleiotropy, and differences among species. Nevertheless, our understanding of chemokine biology is continuing to grow and several promising drugs are currently being tested in late-stage clinical trials. In this review, we examine the role of chemokines in health and diseases and discuss strategies to target the chemokine system.

Citing Articles

Adipokines in Breast Cancer: Decoding Genetic and Proteomic Mechanisms Underlying Migration, Invasion, and Proliferation.

Liessem A, Leimer U, Germann G, Kollensperger E Breast Cancer (Dove Med Press). 2025; 17:79-102.

PMID: 39882382 PMC: 11776935. DOI: 10.2147/BCTT.S491277.


The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.

Russo R, Ryffel B Cells. 2025; 13(24).

PMID: 39768150 PMC: 11674266. DOI: 10.3390/cells13242058.


Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice.

Luo M, Almeida D, Dallacasagrande V, Hedhli N, Gupta M, DAmico D Nat Commun. 2024; 15(1):8757.

PMID: 39384746 PMC: 11464875. DOI: 10.1038/s41467-024-52675-x.


Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2).

Ortiz Zacarias N, Roth S, Broekhuis J, van der Es D, Moreau K, Heitman L Int J Mol Sci. 2024; 25(16).

PMID: 39201670 PMC: 11354370. DOI: 10.3390/ijms25168984.


A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model.

Bober A, Piotrowska A, Pawlik K, Ciapala K, Maciuszek M, Makuch W Int J Mol Sci. 2024; 25(13).

PMID: 39000516 PMC: 11242565. DOI: 10.3390/ijms25137410.